Table 1 Sponsor drug manufacturers subject to expanded access campaigns/petitions
Name of sponsor | Size of companya | Publicly traded? (Yes/No) | Number of requestsb |
|---|---|---|---|
BioMarin Pharmaceutical Inc. | Large | Yes (NASDAQ Stock Market: BMRN) | 1 |
Bayer AG | Large | Yes (Frankfurt Stock Exchange: BAYN) | 1 |
Bristol-Meyers Squibb | Large | Yes (New York Stock Exchange: BMY) | 5 |
Chimerix Inc. | Small | Yes (NASDAQ Stock Market: CMRX) | 1 |
CureTech Ltd. | Small | No | 1 |
Eli Lilly and Company | Large | Yes (New York Stock Exchange: LLY) | 1 |
Genentech Inc. (wholly owned subsidiary of F. Hoffmann-La Roche) | Large | Yes (SIX Swiss Exchange: ROG; OTCQX: RHHBY) | 4 |
ISIS Pharmaceuticals Inc. | Small | Yes (NASDAQ Stock Market: ISIS) | 1 |
MedImmune, LLC (wholly owned subsidiary of AstraZeneca) | Large | Yes (London Stock Exchange, OMX, New York Stock Exchange: AZN) | 1 |
Merck & Co., Inc. | Large | Yes (New York Stock Exchange: MRK) | 8 |
Pfizer Inc. | Large | Yes (New York Stock Exchange: PFE) | 1 |
Pharmacyclics LLC | Large | Yes (NASDAQ Stock Market: PCYC) | 1 |
Shire Plc | Large | Yes (London Stock Exchange: SHP; NASDAQ Stock Market: SHPG) | 1 |
Total number of firms: 13 | Total number of requests: 27 | ||